The COVID19 vaccine and therapeutics clinical trial analysis report consists of drugs and vaccines which are under clinical trials for the treatment of COVID 19. The various drugs and vaccines trials are categorized under 4 phases i.e. Phase I (drug or vaccine safety is tested on a small group of humans), Phase II (efficacy and safety are tested on a large group of humans), Phase III (efficacy and safety are tested on thousands of humans), and Phase IV (obtaining government approval and market launch, many vaccines undergo more monitoring).
Read More On The Global COVID19 Vaccine And Therapeutics Clinical Trial Analysis At –https://www.thebusinessresearchcompany.com/report/covid19-vaccine-and-therapeutics-clinical-trial-analysis
The urgent need to develop vaccines or therapeutics in response to the outbreak of the 2019 Novel Coronavirus (COVID-19) has resulted in a significant increase in clinical trials worldwide. Many research institutes, healthcare organizations and biopharmaceutical companies worldwide are conducting clinical trials for COVID-19 vaccines and therapeutics. According to the ClinicalTrials.gov database, there are more than 1,300 clinical trials registered (195 in phase I, 817 in phase II, 442 in phase III, 188 in phase IV).
Global COVID19 Vaccine And Therapeutics Clinical Trial Analysis Segmentation –
1) By Product: Small Molecules, Biologics, Blood & Plasma Derivatives, Monoclonal Antibodies, Vaccines and Others
2) By Phase of Development: Clinical Phase I (Active trial & Discontinued Trials), Clinical Phase II (Active trial & Discontinued Trials), Clinical Phase III (Active trial & Discontinued Trials), Clinical Phase IV (Active trial & Discontinued Trials)
3) By Route of Administration: Oral, Intravenous, Subcutaneous, Other Route of Administration
4) By Type of Sponsor: Pharma/Biotech Company, Academic Research/Institution, Others such as Government Organizations and CROs
The growing number of coronavirus cases across the globe together with an urgent requirement for vaccine or drug to curb the disease is a major driver for the growth of COVID19 vaccine & therapeutics clinical trials.
Request For A Sample Of The Global COVID19 Vaccine And Therapeutics Clinical Trial Analysis At – https://www.thebusinessresearchcompany.com/sample.aspx?id=3250&type=smp
Few Points From The Global COVID19 Vaccine And Therapeutics Clinical Trial Analysis TOC
1. Executive Summary
2. Disease Epidemiology
2.1 Novel Coronavirus Etiology and Disease Pathogenesis
2.2 COVID-19 Clinical Features – Signs and Symptoms
2.3 Disease Epidemiology and Epidemic Statistics for Major Countries
3. Global Clinical Trial Analysis of COVID-19 Therapeutics and Vaccines
4. Top 10 Late Staged Therapeutics and Vaccine Clinical Trials Analysis
5. Regulatory Framework for COVID-19 Therapeutics and Vaccines Marketing Approvals
6. Recommendations & Conclusion
Interested to know more about The Business Research Company?
The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.
Company Name: The Business Research Company
Contact Person: Oliver Guirdham
Email: Send Email
Phone: +44 20 7193 0708
State: Greater London
Country: United Kingdom